To access this element change to forms mode OFF
Grant Award View - GA30216
Improving treatment options for pancreatic cancer
GA ID:
GA30216
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$892,284.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Improving treatment options for pancreatic cancer
Purpose:
We have developed promising new anti-cancer drugs which enable drug access into cancers which are normally impenetrable. We are now seeking funds to optimize these drugs and develop combination therapies for pancreatic cancer, an aggressive and incurable disease. We expect that these new treatment options will lead to reduced metastatic spreading, enhanced response to chemo- and immunotherapies and improved overall patient survival.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1157240
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Western Australia
Recipient ABN:
37 882 817 280
Grant Recipient Location
Suburb:
Nedlands
Town/City:
Nedlands
Postcode:
6009
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
WA
Postcode:
Country:
AUSTRALIA